BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12126617)

  • 1. The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents.
    Guilloteau JP; Mathieu M; Giglione C; Blanc V; Dupuy A; Chevrier M; Gil P; Famechon A; Meinnel T; Mikol V
    J Mol Biol; 2002 Jul; 320(5):951-62. PubMed ID: 12126617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure analysis of peptide deformylases from Streptococcus pneumoniae, Staphylococcus aureus, Thermotoga maritima and Pseudomonas aeruginosa: snapshots of the oxygen sensitivity of peptide deformylase.
    Kreusch A; Spraggon G; Lee CC; Klock H; McMullan D; Ng K; Shin T; Vincent J; Warner I; Ericson C; Lesley SA
    J Mol Biol; 2003 Jul; 330(2):309-21. PubMed ID: 12823970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
    Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
    Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion.
    Meinnel T; Lazennec C; Villoing S; Blanquet S
    J Mol Biol; 1997 Apr; 267(3):749-61. PubMed ID: 9126850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of peptide deformylase from Staphylococcus aureus in complex with actinonin, a naturally occurring antibacterial agent.
    Yoon HJ; Kim HL; Lee SK; Kim HW; Kim HW; Lee JY; Mikami B; Suh SW
    Proteins; 2004 Nov; 57(3):639-42. PubMed ID: 15382235
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
    Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
    Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.
    Smith KJ; Petit CM; Aubart K; Smyth M; McManus E; Jones J; Fosberry A; Lewis C; Lonetto M; Christensen SB
    Protein Sci; 2003 Feb; 12(2):349-60. PubMed ID: 12538898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N.
    Ganji RJ; Reddi R; Gumpena R; Marapaka AK; Arya T; Sankoju P; Bhukya S; Addlagatta A
    Protein Sci; 2015 May; 24(5):823-31. PubMed ID: 25644575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YkrB is the main peptide deformylase in Bacillus subtilis, a eubacterium containing two functional peptide deformylases.
    Haas M; Beyer D; Gahlmann R; Freiberg C
    Microbiology (Reading); 2001 Jul; 147(Pt 7):1783-1791. PubMed ID: 11429456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene.
    Margolis PS; Hackbarth CJ; Young DC; Wang W; Chen D; Yuan Z; White R; Trias J
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1825-31. PubMed ID: 10858337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of peptide deformylase2 from B. cereus.
    Park JK; Kim KH; Moon JH; Kim EE
    J Biochem Mol Biol; 2007 Nov; 40(6):1050-7. PubMed ID: 18047803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.
    Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-induced changes in the structure and dynamics of Escherichia coli peptide deformylase.
    Amero CD; Byerly DW; McElroy CA; Simmons A; Foster MP
    Biochemistry; 2009 Aug; 48(32):7595-607. PubMed ID: 19627112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H, 13C and 15N NMR assignments of the E. coli peptide deformylase in complex with a natural inhibitor called actinonin.
    Larue V; Seijo B; Tisne C; Dardel F
    Biomol NMR Assign; 2009 Jun; 3(1):153-5. PubMed ID: 19636969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a human peptide deformylase: implications for antibacterial drug design.
    Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
    Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of type II peptide deformylase from Staphylococcus aureus.
    Baldwin ET; Harris MS; Yem AW; Wolfe CL; Vosters AF; Curry KA; Murray RW; Bock JH; Marshall VP; Cialdella JI; Merchant MH; Choi G; Deibel MR
    J Biol Chem; 2002 Aug; 277(34):31163-71. PubMed ID: 12048187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the Escherichia coli peptide deformylase.
    Chan MK; Gong W; Rajagopalan PT; Hao B; Tsai CM; Pei D
    Biochemistry; 1997 Nov; 36(45):13904-9. PubMed ID: 9374869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization and preliminary X-ray crystallographic analysis of peptide deformylase from Pseudomonas aeruginosa.
    Kim HW; Han BW; Yoon HJ; Yang JK; Lee BI; Lee HH; Ahn HJ; Suh SW
    Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1874-5. PubMed ID: 12351843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-crystallization of Staphylococcus aureus peptide deformylase (PDF) with potent inhibitors.
    Harris MS; Bock JH; Choi G; Cialdella JS; Curry KA; Deibel MR; Jacobsen EJ; Marshall VP; Murray RW; Vosters AF; Wolfe CL; Yem AW; Baldwin ET
    Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2153-6. PubMed ID: 12454484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal Structures of Peptide Deformylase from Rice Pathogen Xanthomonas oryzae pv. oryzae in Complex with Substrate Peptides, Actinonin, and Fragment Chemical Compounds.
    Ngo HP; Ho TH; Lee I; Tran HT; Sur B; Kim S; Kim JG; Ahn YJ; Cha SS; Kang LW
    J Agric Food Chem; 2016 Oct; 64(39):7307-7314. PubMed ID: 27616570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.